Cases of Novel Coronavirus (COVID-19) infection are rising every day across the world. Acute respiratory failure is one of the commonest causes of death among COVID-19 patients as this infection can inflame the respiratory tract and fill an infected person’s lungs in fluids. Ventilator, a device that mechanically helps pump oxygen into the lungs, is very important to save critical lives infected by COVID-19. India is presently grappling with an acute shortage of ventilators in its fight against coronavirus.
Ventilators do not fall under any regulated medical device category at present in India. There are only 23 categories of medical devices that are regulated by the Central Drugs Standard Control Organization (CDSCO).Ventilators may also be coming under the regulated category soon. Once this happens the present regulatory pathways followed for ventilators will change and manufacturers or importers need to apply for manufacturing license or import license.
If anyone intends to check the performance of ventilators, he may approach below NABL accredited labs:
Present Steps of registration of Ventilators during COVID-19 Pandemic in India:
Manufacturers or importers need to follow the above regulatory pathway until CDSCO comes up with the new rules for registration of ventilators in India. The new rules are expected to streamline the framework. This might have a substantial positive impact on patent care in India. It will be helpful to the healthcare ecosystem if they get more clarity on the future regulation of ventilators.
For any ventilator related regulatory approval and submission, you can talk with CliniExperts. Our team can provide you the necessary guidance for the rapid regulatory approval of ventilators in India.
Government eases controls, taps automakers to manufacture ventilator. Available at:https://www.livemint.com/industry/manufacturing/government-eases-controls-taps-automakers-to-manufacture-ventilator-11585249572752.html . Accessed on 9 th may,
2020.
Gsr102eRegistration of certain medical devices.pdf.Available at https://cdsco.gov.in/opencms/opencms/system/modules/CDSCO.WEB/elements/downlo .Accessed on 9 th May, 2020.
India occupies a unique position in the global vaccine ecosystem — simultaneously the world’s largest vaccine manufacturer by volume (producing approximately 60% of the world’s vaccines)..
In Pharmaceutical development, time is capital. Every month of delay between trial design and first patient enrolled has a quantifiable cost – in direct operational expenditure, in foregone reve..
The Certificate That Does Not Automatically Renew The COS-2 Import Registration Certificate is valid for five years from the date of issue. When it expires, the right to import and market the re..
India
Global
Sales: +91 7672005050
Reception: +91-11-45214546
9 am to 6 pm (Monday to Friday)